US Congress Senate Bill 2295 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on April 18 2012 - 25% progression, died in committee
Action: 2012-04-18 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2498)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Patient Safety and Generic Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application. Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug.

Patient Safety and Generic Labeling Improvement Act

Sen. Patrick Leahy [D-VT]	Sen. Mark Begich [D-AK]	Sen. Jeff Bingaman [D-NM]	Sen. Richard Blumenthal [D-CT]
Sen. Sherrod Brown [D-OH]	Sen. Christopher Coons [D-DE]	Sen. Al Franken [D-MN]	Sen. Sheldon Whitehouse [D-RI]

Date	Chamber	Action
2012-04-18	Senate	Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2498)
2012-04-18	Senate	Sponsor introductory remarks on measure. (CR S2497-2498, S2499-2500)

HB4384 (Related) 2012-04-20 - Referred to the Subcommittee on Health.

Type	Source
Summary	https://www.congress.gov/bill/112th-congress/senate-bill/2295/all-info
Text	https://www.congress.gov/112/bills/s2295/BILLS-112s2295is.pdf